BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1879447)

  • 1. Radionuclide therapy revisited.
    Hoefnagel CA
    Eur J Nucl Med; 1991; 18(6):408-31. PubMed ID: 1879447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer radiopharmaceuticals.
    Hoefnagel CA
    Anticancer Drugs; 1991 Apr; 2(2):107-32. PubMed ID: 1958857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclide cancer therapy.
    Hoefnagel CA
    Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide therapy of tumors: general aspects and considerations.
    Hoefnagel CA
    Int J Biol Markers; 1993; 8(3):172-9. PubMed ID: 8277209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide therapy.
    Chatal JF; Hoefnagel CA
    Lancet; 1999 Sep; 354(9182):931-5. PubMed ID: 10489968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic radionuclides in nuclear medicine: current and future prospects.
    Yeong CH; Cheng MH; Ng KH
    J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
    Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
    Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of therapeutic radionuclides in medicine.
    Early PJ; Landa ER
    Health Phys; 1995 Nov; 69(5):677-94. PubMed ID: 7558861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.
    Erickson BA; Bittner NH; Chadha M; Mourtada F; Demanes DJ
    Brachytherapy; 2017; 16(1):75-84. PubMed ID: 28109634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiologic principles in radionuclide therapy.
    Kassis AI; Adelstein SJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():4S-12S. PubMed ID: 15653646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered affinity proteins for tumour-targeting applications.
    Friedman M; Ståhl S
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
    Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ
    Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd.
    Antipas V; Dale RG; Coles IP
    Phys Med Biol; 2001 Oct; 46(10):2557-69. PubMed ID: 11686275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of nuclear medicine to the therapy of malignant tumors.
    Feinendegen LE
    Strahlenther Onkol; 1991 Nov; 167(11):619-27. PubMed ID: 1962275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour therapy with radionuclides: assessment of progress and problems.
    Carlsson J; Forssell Aronsson E; Hietala SO; Stigbrand T; Tennvall J
    Radiother Oncol; 2003 Feb; 66(2):107-17. PubMed ID: 12648782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.
    Panigone S; Nunn AD
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):310-21. PubMed ID: 17043628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of radiobiological concepts in radionuclide therapy of cancer.
    Kumar C; Shetake N; Desai S; Kumar A; Samuel G; Pandey BN
    Int J Radiat Biol; 2016; 92(4):173-86. PubMed ID: 26917443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy.
    Bakht MK; Sadeghi M
    Ann Nucl Med; 2011 Oct; 25(8):529-35. PubMed ID: 21720780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.